|
|
Diagnostic value of fluorescence PCR melting curve method for drug resistance of Isoniazid, Ethambutol, and Levofloxacin against tuberculosis#br# |
SHI Jianquan1 GAO Shan2 WANG Jun2 |
1.Department of Critical Care Medicine, Beijing Chest Hospital, Capital Medical University, Beijing 101149, China;
2.Department of Internal Medicine-Tuberculosis, Beijing Chest Hospital, Capital Medical University, Beijing 101149, China |
|
|
Abstract Objective To evaluate the diagnostic value of fluorescence PCR melting curve method for drug resistance of Isoniazid, Ethambutol, and Levofloxacin against tuberculosis. Methods A retrospective analysis was performed on 170 tuberculosis patients admitted to Beijing Chest Hospital, Capital Medical University from January 2018 to December 2019. A comparison was made between phenotypic drug susceptibility testing (DST) and fluorescence PCR melting curve method for anti-tuberculosis drug resistance. The diagnostic value of fluorescence PCR melting curve method for anti-tuberculosis drug resistance was analyzed using phenotypic DST results as the gold standard. The evaluation indexes included sensitivity, specificity, coincidence rate, Kappa value, and area under the curve (AUC) value. The drug resistance of quinolones (Levofloxacin and Moxifloxacin) was further compared. Results The number of cases of DST sensitivity by fluorescence PCR melting curve method and phenotype DST resistance was 5 cases in Isoniazid, 5 cases in Ethambutol, and 3 cases in Leofloxacin. The number of cases with DST resistance by fluorescence PCR melting curve method and phenotype DST sensitive was 9 cases in Isoniazid, 16 cases in Ethambutol, and 24 cases in Leofloxacin. The overall inconsistent rates of Isoniazid, Ethambutol, and Levofloxacin were 8.24%, 12.35%, and 15.88%, respectively. The sensitivity, specificity, coincidence rate, Kappa value, and AUC value of fluorescence PCR melting curve method to detect Isoniazid resistance were 91.53%, 91.89%, 91.76%, 0.821, and 0.917, respectively; the sensitivity, specificity, coincidence rate, Kappa value, and AUC value of fluorescence PCR melting curve method to detect Ethambutol resistance were 77.27%, 89.19%, 87.65%, 0.548, and 0.832, respectively; the sensitivity, specificity, coincidence rate, Kappa value, and AUC value of fluorescence PCR melting curve method to detect Levofloxacin resistance were 89.66%, 82.98%, 84.12%, 0.564, and 0.863, respectively. The drug resistance rate of Moxifloxacin against Mycobacterium tuberculosis (2.94%) was significantly lower than that of Levofloxacin (17.06%) (P < 0.01). Conclusion Fluorescence PCR melting curve method has good auxiliary diagnostic value for drug resistance of Isoniazid, Ethambutol, and Levofloxacin.
|
|
|
|
|
[1] World Health Organization. Global tuberculosis report 2020 [M]. Geneva:World Health Organization,2020.
[2] 宋婧,张治国,董宇杰,等.扩增子测序技术检测石蜡包埋组织标本耐药结核基因的研究[J].中华结核和呼吸杂志,2020,43(3):234-241.
[3] 陈俊林,黄飞,徐费凡,等.Xpert MTB/RIF与BACTEC MGIT960检测结核分枝杆菌及利福平耐药差异性[J].中国医药导报,2018,15(1):49-52.
[4] 刘春平,熊德芳,谭耀驹.两种分子检测技术对结核分枝杆菌临床分离株耐药性诊断价值的评价[J].临床肺科杂志,2021,26(6):815-819.
[5] 中华医学会结核病学分会,结核病病理学诊断专家共识编写组.中国结核病病理学诊断专家共识[J].中华结核和呼吸杂志,2017,40(6):419-425.
[6] Filipenko ML,Dymova MA,Cherednichenko AG,et al. Detection of Mutations in Mycobacterium tuberculosis pncA Gene by Modified High-Resolution Melting Curve Analysis of PCR Products [J]. Bull Exp Biol Med,2019,168(2):264-269.
[7] Nahid P,Mase SR,Migliori GB,et al. Treatment of Drug-Resistant Tuberculosis. An Official ATS/CDC/ERS/IDSA Clinical Practice Guideline [J]. Am J Respir Crit Care Med,2019,200(10):e93-e142.
[8] 刘一典,桂徐蔚,申晓娜,等. 2019年《ATS/CDC/ERS/IDSA临床实践指南:耐药结核病治疗》解读及与我国《耐药结核病化学治疗指南(2019年)》对比[J].中国防痨杂志,2020,42(1):5.
[9] Robledo CA,Yeung EH,Mendola P,et al. Examining the Prevalence Rates of Preexisting Maternal Medical Conditions and Pregnancy Complications by Source:Evidence to Inform Maternal and Child Research [J]. Matern Child Health J,2017,21(4):852-862.
[10] 颜虹,徐勇勇.医学统计学[M].3版.北京:人民卫生出版社,2015:230.
[11] 吴慧娜,孙付胜,刘清文,等.荧光PCR探针熔解曲线法检测结核分枝杆菌复合群对利福平和异烟肼耐药性的价值[J].中国防痨杂志,2019,41(1):74-79.
[12] 刘艳,古丽比克·木拉提,玛力亚木·阿布力提甫,等.荧光PCR熔解曲线法检测结核分枝杆菌耐药基因的结果分析[J].中国防痨杂志,2018,40(9):959-963.
[13] 曹志华,赵悦竹,胡双双.荧光PCR探针熔解曲线技术检测结核分枝杆菌对五种抗结核药物耐药性的研究[J].中国防痨杂志,2019,41(2):156-161.
[14] 刘春平,谭耀驹,苏碧仪,等.荧光PCR探针熔解曲线法检测结核分枝杆菌对利福平、异烟肼、喹诺酮及卡那霉素耐药性的评价[J].广东医学,2021,42(4):377-381.
[15] 李爱芳,崔晓利,康磊,等.荧光PCR探针熔解曲线法检测结核分枝杆菌耐药性的价值[J].中国防痨杂志,2020,42(9):998-1002.
[16] 田际云,武洁,李静,等.熔解曲线法在结核分枝杆菌药敏试验质量评估中的应用[J].中华结核和呼吸杂志,2015,38(2):105-109.
[17] 宋婧,车南颖.结核分枝杆菌耐药机制和检测方法的研究进展[J].中国医药导报,2018,15(29):29-34.
[18] Payne JL,Menardo F,Trauner A,et al. Transition bias influences the evolution of antibiotic resistance in Mycobacterium tuberculosis [J]. PLoS Biol,2019,17(5):e3000265. doi:10.1371/journal.pbio.3000265.
[19] Khan MT,Malik SI,Ali S,et al. Pyrazinamide resistance and mutations in pncA among isolates of Mycobacterium tuberculosis from Khyber Pakhtunkhwa:Pakistan [J]. BMC Infect Dis,2019,19(1):116.
[20] 袁阳,张泓,陈玲.结核分枝杆菌异质性耐药诊断方法的研究进展[J].实用心脑肺血管病杂志,2018,26(1):1-6.
[21] Anyansi C,Keo A,Walker BJ,et al. QuantTB - a method to classify mixed Mycobacterium tuberculosis infections within whole genome sequencing data [J]. BMC Genomics,2020,21(1):80.
[22] 王佩,赵国连,雷倩,等.荧光PCR探针熔解曲线法与微孔板法检测MTB耐药性的临床应用比较[J].中国防痨杂志,2021,43(2):132-138.
[23] 柳清云,孙刚,高谦.结核分枝杆菌(MTB)异质性耐药研究进展[J].复旦学报:医学版,2013,40(1):1-4.
[24] 宋怡蒙,李远春,贺文从,等.荧光PCR探针熔解曲线技术检测MTB耐药性的成本分析[J].中国防痨杂志,2020,42(7):712-717.
[25] 王悦,孟湃喆,于艳红.荧光PCR熔解曲线技术在结核病耐药诊断中的应用价值[J].中国当代医药,2021,28(20):194-197.
[26] 张汇征,李桓,张珍,等.荧光PCR熔解曲线法在检测临床标本结核分枝杆菌及其耐药性中的应用[J].中国实验诊断学,2021,25(3):354-356. |
|
|
|